EU: Temporary VAT exemption for vaccines and testing kits (COVID-19)

EU: Temporary VAT exemption for vaccines, testing kits

The European Commission today issued a release concerning value added tax (VAT) relief measures allowing EU Member States to provide a VAT exemption for EU hospitals, medical practitioners, and individuals when acquiring coronavirus (COVID-19) vaccines and testing kits.


As noted in an EC release, the new rules were adopted unanimously by all EU Member States.

The measures will allow EU countries to put in place a temporary VAT exemption for vaccines and testing kits being sold to hospitals, doctors, and individuals. Currently, EU Member States can apply reduced VAT rates on sales of vaccines but cannot apply a zero rate, while testing kits cannot benefit from reduced rates. Under the amended Directive, EU Member States will be able to apply either reduced or zero rates to both vaccines and testing kits. 

The new rules will apply from the day after their publication in the Official Journal of the European Union and will remain in place until the end of 2022, or until an agreement is reached on the EC's pending proposal for new rules on VAT rates, whichever is earlier.    

© 2022 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organization please visit

The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us